Caryn Peterson

Ms. Caryn L.
Peterson is an Independent Director at Aspen Neuroscience, Inc., a Chief Development Officer at Gossamer Bio, Inc. and a Chief Executive Officer at Alevium Pharmaceuticals, Inc. She is on the Board of Directors at Aspen Neuroscience, Inc. Ms. Peterson was previously employed as a Vice President-Regulatory Affairs by OncoSec Medical, Inc., a Vice President-Regulatory Affairs by Syndax Pharmaceuticals, Inc., a Managing Partner by DSC Associates LLC, a Vice President-Regulatory Affairs by FeRx, Inc., an Associate Director-Regulatory Affairs by Amylin Pharmaceuticals, Inc., a Principal by Hybritech, Inc., and a Vice President-Regulatory Affairs by Ascenta Therapeutics, Inc.